KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

80 hedge funds and large institutions have $456M invested in Chinook Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 80 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$66K
Puts
$231K
Net Calls
Net Calls Change

Top Buyers

1
+$157M
2
+$63.9M
3
+$34.9M
4
O
OrbiMed
New York
+$32.3M
5
Jennison Associates
Jennison Associates
New York
+$22.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.84M
27
$1.77M
28
$1.32M
29
$1.3M
30
$1.21M
31
$1.2M
32
$1.15M
33
$1.06M
34
$1.04M
35
$992K
36
$883K
37
$635K
38
$597K
39
$491K
40
$462K
41
$442K
42
$430K
43
$409K
44
$367K
45
$355K
46
$338K
47
$310K
48
$295K
49
$273K
50
$248K
1
2
3 4